Created date

Published on

You are here:

MS in the media - 8 December 2017

2 - 8 December 2017

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

Diet and MS studied

An American study asked participants to fill in questionnaires about what they ate. They were then grouped into five bands based on the healthiness of their diet. The healthiest group (who ate more fruit, veg and whole grains) were 20% less likely to have severe disabilities or to have depression. Study didn't look at whether diet affected MS or whether having MS affected the ability to eat healthily

Source: Science Daily

MS Trust link: Diet

Laquinimod trial for PPMS unsuccessful

A 48 week, phase 2 trial of laquinimod for primary progressive MS failed to show any effect on slowing loss of brain tissue (atrophy) or measures of progression

Source: National MS Society (USA)

MS Trust link: Laquinimod

Epilepsy and MS

People with MS have a higher risk of also getting epilepsy, according to a study of records from the Swedish MS register. In the general population the risk of epilepsy was 1.4%. In people with relapsing remitting MS, the risk was 2.2% and for people with progressive MS it was 5.5%

Source: Neurology Advisor

MS Trust link: MS research updates

Stem cell therapy consensus report

A recently published consensus report from a 2015 conference on stem cells looks at some of the benefits, risks and challenges of stem cell treatment. It identified great potential but considers the approach still to be experimental. It also warns about "clinics based in jurisdictions with less stringent medical regulatory structures".

Source: MD Magazine

MS Trust link: Stem cell therapy